Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
MMWR Morb Mortal Wkly Rep
; 66(22): 579-583, 2017 Jun 09.
Article
en En
| MEDLINE
| ID: mdl-28594790
ABSTRACT
Japanese encephalitis (JE) virus is the most important vaccine-preventable cause of encephalitis in the Asia-Pacific region. The World Health Organization (WHO) recommends integration of JE vaccination into national immunization schedules in all areas where the disease is a public health priority (1). This report updates a previous summary of JE surveillance and immunization programs in Asia and the Western Pacific in 2012 (2). Since 2012, funding for JE immunization has become available through the GAVI Alliance, three JE vaccines have been WHO-prequalified,* and an updated WHO JE vaccine position paper providing guidance on JE vaccines and vaccination strategies has been published (1). Data for this report were obtained from a survey of JE surveillance and immunization practices administered to health officials in countries with JE virus transmission risk, the 2015 WHO/United Nations Children's Fund Joint Reporting Form on Immunization, notes and reports from JE meetings held during 2014-2016, published literature, and websites. In 2016, 22 (92%) of 24 countries with JE virus transmission risk conducted JE surveillance, an increase from 18 (75%) countries in 2012, and 12 (50%) countries had a JE immunization program, compared with 11 (46%) countries in 2012. Strengthened JE surveillance, continued commitment, and adequate resources for JE vaccination should help maintain progress toward prevention and control of JE.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vigilancia de la Población
/
Encefalitis Japonesa
/
Vacunas contra la Encefalitis Japonesa
Tipo de estudio:
Guideline
/
Screening_studies
Límite:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
País/Región como asunto:
Asia
/
Oceania
Idioma:
En
Revista:
MMWR Morb Mortal Wkly Rep
Año:
2017
Tipo del documento:
Article